Drug Registration and Acceptance

Drug Name

Exact

Active Ingredient

Acceptance No.

Manufacturers

Acceptance Date

Status Date

Classification

Review Status

Drug Type

Submission

Evaluation Conclusion

ATC Category

Special Approval Varieties

Task Type

Major Special Varieties

Sequence No.

Stock Code

Visualized Analysis Export Evaluation Conclusion Evaluation Progress

Acceptance No.	Drug Name	Active Ingredient	Dosage Form	Classification	Submission	Acceptance Date	Manufacturers	Manufacturers	Review Status	Status Date	View
CXSB2000082	重组质粒-肝细胞生长因子注射液		Injection	Biological Products	Supplementary Application	2020-10-28	武汉光谷人福生物医药有限公司	Wuhan Optical Valley Humanwell Biological Pharmaceutical Co Ltd	In Review	2020-10-27	view
CXHB1700003	美索舒利片		Tablet	Chemical Drugs	Supplementary Application	2017-06-30	武汉光谷人福生物医药有限公司	Wuhan Optical Valley Humanwell Biological Pharmaceutical Co Ltd;The Institute of Radiation Medicine Academy of Military Medical Sciences PLA	Certificate Issued	2017-11-30	view
CXHB1700004	美索舒利片		Tablet	Chemical Drugs	Supplementary Application	2017-06-30	武汉光谷人福生物医药有限公司	Wuhan Optical Valley Humanwell Biological Pharmaceutical Co Ltd;The Institute of Radiation Medicine Academy of Military Medical Sciences PLA	Certificate Issued	2017-11-30	view
CXHB1700002	美索舒利	Methosulide	Active ingredient	Chemical Drugs	Supplementary Application	2017-06-23	武汉光谷人福生物医药有限公司	Wuhan Optical Valley Humanwell Biological Pharmaceutical Co Ltd;The Institute of Radiation Medicine Academy of Military Medical Sciences PLA	Certificate Issued	2017-11-30	view